Harish Kothandaraman: h-index, Total Citations, and Citation Map
Harish Kothandaraman's h-index is 8 (7 i10-index, 243+ total citations across 29+ publications) according to Google Scholar as of May 2026. Harish Kothandaraman is affiliated with Purdue Institute for Cancer Research.
Harish Kothandaraman is a researcher affiliated with Purdue Institute for Cancer Research, specializing in Genomics, Epigenomics, Transcriptomics. Their work has been cited 243 times. This profile visualizes their global influence, highlighting strong citation networks in United States.
Harish Kothandaraman's Citation Metrics
Bibliometric impact based on 29 indexed publications. Of these, 19 are original research articles — the rest are literature highlights, conference abstracts or theses.
- H-Index
- 8
- i10-Index
- 7
- Total Citations
- 243
- Citing Countries
- 25
As of May 2026.
Harish Kothandaraman has an h-index of 8 and 243 total citations across 29 publications, with research cited by institutions in 25 countries.
Download Exports (PNG, CSV, Poster)
Free Viewing Harish Kothandaraman's citation map is always free. Pay once to download poster, PNG, and CSV files for offline use or your visa packet.
Global Impact Map
Visualizing the geographic distribution of institutions that have cited your work.
Starting…
Pins will appear here as institutions are resolved — no need to refresh.
Top Cited Works
Tip: clickto hide a row from the map
A first-in-class fully modified version of miR-34a with outstanding stability, activity, and anti-tumor efficacy
202370
Top Citing Countries
Top Citing Institutions
Visa Evidence Package
Views and exports tuned for EB-1A, O-1A, and EB-2 NIW petitions. Sustained acclaim, geographic reach, and independent-citation filtering are the strongest evidence categories immigration adjudicators look for.
Significant Contributions
Auto-detected research lines — a seminal paper and the follow-up work building on it. Review and edit before using in a petition. Each Free PDF opens in a new tab — EB-1A organises this into the structure USCIS applies to Criterion 5 of 8 CFR § 204.5(h)(3)(v); EB-1B re-frames it under § 204.5(i)(3) (outstanding researcher); NIW presents it under prong 2 of Matter of Dhanasar.
122 citing papers could not be classified (no author data) — excluded from the percentages above.
The researcher identified a new class of antibacterial proteins by developing methods to predict peptidoglycan hydrolases, establishing a foundational framework for discovering novel antimicrobial targets.
The researcher developed a first-in-class fully modified miR-34a variant demonstrating superior stability, activity, and anti-tumor efficacy, establishing a novel therapeutic platform for oncology.
The researcher developed methods for reconstructing bacterial and viral genomes from multiple metagenomes, a foundational approach that has garnered significant independent scholarly attention.
Citation trend (last 10 years)Click to expand
Citation Trend (Last 10 Years)
Related Guides
Learn how to use citation maps for your research and visa applications.
